Yunnan Energy International Past Earnings Performance
Past criteria checks 2/6
Yunnan Energy International has been growing earnings at an average annual rate of 33.2%, while the Healthcare industry saw earnings growing at 5.8% annually. Revenues have been growing at an average rate of 12.7% per year. Yunnan Energy International's return on equity is 0.4%, and it has net margins of 0.1%.
Key information
33.2%
Earnings growth rate
33.2%
EPS growth rate
| Healthcare Industry Growth | 9.7% |
| Revenue growth rate | 12.7% |
| Return on equity | 0.4% |
| Net Margin | 0.1% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Yunnan Energy International makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 454 | 1 | 14 | 0 |
| 31 Mar 24 | 398 | -2 | 15 | 0 |
| 31 Dec 23 | 342 | -5 | 15 | 0 |
| 30 Sep 23 | 312 | -10 | 15 | 0 |
| 30 Jun 23 | 282 | -15 | 16 | 0 |
| 31 Mar 23 | 285 | -12 | 15 | 0 |
| 31 Dec 22 | 288 | -9 | 14 | 0 |
| 30 Sep 22 | 233 | -3 | 11 | 0 |
| 30 Jun 22 | 177 | 3 | 7 | 0 |
| 31 Mar 22 | 131 | -12 | 8 | 0 |
| 31 Dec 21 | 84 | -27 | 9 | 0 |
| 30 Sep 21 | 63 | -56 | 17 | 0 |
| 30 Jun 21 | 42 | -85 | 25 | 0 |
| 31 Mar 21 | 51 | -73 | 27 | 0 |
| 31 Dec 20 | 61 | -62 | 30 | 0 |
| 30 Sep 20 | 125 | -37 | 36 | 0 |
| 30 Jun 20 | 188 | -12 | 43 | 0 |
| 31 Mar 20 | 250 | -16 | 64 | 0 |
| 31 Dec 19 | 311 | -20 | 86 | 0 |
| 30 Jun 19 | 493 | -27 | 130 | 0 |
| 31 Mar 19 | 564 | -17 | 137 | 0 |
| 31 Dec 18 | 634 | -8 | 145 | 0 |
| 30 Jun 18 | 821 | 114 | 36 | -12 |
| 31 Mar 18 | 982 | 109 | 97 | -6 |
| 31 Dec 17 | 1,137 | 104 | 158 | 0 |
| 30 Sep 17 | 1,500 | 5 | 384 | 47 |
| 30 Jun 17 | 1,443 | 0 | 390 | 57 |
| 31 Mar 17 | 1,429 | 4 | 396 | 51 |
| 31 Dec 16 | 1,419 | 8 | 403 | 45 |
| 30 Sep 16 | 1,504 | 23 | 419 | 42 |
| 30 Jun 16 | 1,380 | 22 | 403 | 20 |
| 31 Mar 16 | 1,375 | 35 | 391 | 20 |
| 31 Dec 15 | 1,332 | 27 | 380 | 20 |
| 30 Sep 15 | 1,303 | 27 | 365 | 0 |
| 30 Jun 15 | 1,294 | 28 | 364 | 0 |
| 31 Mar 15 | 1,287 | 25 | 361 | 0 |
| 31 Dec 14 | 1,262 | 27 | 352 | 0 |
| 30 Sep 14 | 1,225 | 22 | 347 | 0 |
| 30 Jun 14 | 1,281 | 25 | 357 | 0 |
| 31 Mar 14 | 1,299 | 31 | 363 | 0 |
| 31 Dec 13 | 1,291 | 29 | 362 | 0 |
Quality Earnings: T43 has a large one-off gain of HK$166.0K impacting its last 12 months of financial results to 30th June, 2024.
Growing Profit Margin: T43 became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: T43 has become profitable over the past 5 years, growing earnings by 33.2% per year.
Accelerating Growth: T43 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: T43 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (-35.5%).
Return on Equity
High ROE: T43's Return on Equity (0.4%) is considered low.